AbbVie Inc. (TSX:ABBV)
36.61
+0.52 (1.44%)
Oct 2, 2026, 3:50 PM EST
AbbVie Market Cap
AbbVie has a market cap or net worth of CAD 662.06 billion as of October 2, 2026. Its market cap has increased by 9.92% in one year.
Market Cap
662.06B
Enterprise Value
753.82B
Revenue
91.43B
Ranking
n/a
PE Ratio
74.36
Stock Price
36.61
ChartMarket Cap Chart
Since December 10, 2012, AbbVie's market cap has increased from 54.62B to 662.06B, an increase of 1,112.18%. That is a compound annual growth rate of 19.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 662.06B | 19.57% |
| Dec 31, 2025 | 553.70B | 22.55% |
| Dec 31, 2024 | 451.83B | 25.04% |
| Dec 29, 2023 | 361.33B | -6.56% |
| Dec 30, 2022 | 386.68B | 27.65% |
| Dec 31, 2021 | 302.92B | 25.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apotex Health | 7.20B |
| Curaleaf Holdings | 4.07B |
| Extendicare | 2.83B |
| Sienna Senior Living | 2.24B |
| Green Thumb Industries | 2.05B |
| Cronos Group | 1.73B |
| WELL Health Technologies | 1.16B |
| Knight Therapeutics | 1.04B |